36
Participants
Start Date
November 18, 2015
Primary Completion Date
May 18, 2016
Study Completion Date
August 11, 2016
Vericiguat (BAY1021189)
Vericiguat up-titration from 2.5 mg to 10 mg in an interval of 14 +/- 3 days: 2.5 mg vericiguat for 14 +/-3 days given as 2 x 1.25 mg tablets followed by 5 mg vericiguat for 14 +/-3 days given as 1 x 5 mg tablet followed by 10 mg vericiguat for 14 +/-3 days given as 2 x 5 mg tablets
Placebo
Placebo for 14 +/-3 days given as 1 or 2 tablets \[o.d.\].
Nitroglycerin
0.4 mg nitroglycerin spray administered at 2.5 hours before treatment (vericiguat \[trough\] or placebo) on day 12, day 26 and day 40 at 4 hours after treatment (vericiguat \[peak\] or placebo) on day 13, day 27 and day 41
Berlin
Hamburg
Wuppertal
Bonn
Heidelberg
Erfurt
Lead Sponsor
Merck Sharp & Dohme LLC
INDUSTRY
Bayer
INDUSTRY